Table 1.
KTx group n = 29 |
Dx group n = 17 |
P value | |
---|---|---|---|
Age*, years | 13.0 (10.5–18.2) | 13.7 (7.2–17) | 0.67 |
Sex, female/male, n | 14/15 | 6 / 11 | 0.54 |
RRT durationa, months | 24.4 (5.2–63.8) | 15.9 (10.0–23.1) | 0.18 |
Primary kidney disease, n | 0.46 | ||
CAKUT | 9 | 7 | |
Glomerular disease | 8 | 6 | |
Ciliopathies | 8 | 2 | |
Others | 4 | 2 | |
Comorbid conditions, n | |||
Hypertension | 18 | 12 | 0.75 |
Obesity | 9 | 1 | 0.07 |
Other comorbid conditions | 6 | 8 | 0.10 |
Pulmonary disease | 3 | 1 | |
Cardiac problems | 1 | 3 | |
Malignancies | 2 | 2 | |
Others | 0 | 2 | |
Vaccination status, n | |||
Pneumococcus | 19 | 11 | 1.0 |
Influenza | 11 | 3 | 0.25 |
KTx kidney transplantation, Dx dialysis, RRT renal replacement therapy, CAKUT congenital anomalies of the kidney and urinary tract
aData presented as median (quartile 1–quartile 3)